/
FDA Oncology Full Consolidated Comments
FDA Oncology Full Consolidated Comments
Overview |
This file contains the consolidated comments from the FDA Oncology Safety Data Standards Project Team. The goals of this phase of the project was to obtain broad industry and CRO feedback on version 1.3 of the OCE/OOD standard safety data request. The comments in the following tabs should not be considered as the consolidated opinion of the project team but the complete set of feedback collected from project team members for consideration to be included in a future version of the specifications. No indication is given to the status of the comments. |
Related content
FDA Oncology Safety Data Standards
FDA Oncology Safety Data Standards
More like this
Overall Safety Assessment – Standard Safety Tables and Figures
Overall Safety Assessment – Standard Safety Tables and Figures
More like this
Safety Analytics
Safety Analytics
More like this
Nonclinical Working Group Industry Discussion Group
Nonclinical Working Group Industry Discussion Group
More like this